In 2020, Lundbeck La Jolla Research Center Inc. published a patentincluding pyridinyl urea derivatives as ABHD12 inhibitors, which maybe useful for the treatment of cancer and infectious, neurodegenerative,autoimmune, and neuroinflammatory diseases.200 The most potent inhibitor of this series was compound 60 (Figure 14), possessingthe same structure of compound 57 (Figure 14) with the exception of theurea instead of the thiourea moiety. The gene discussed is ABHD12; the disease is cancer.